Stay updated on Mylan Insulin Glargine Safety Clinical Trial
Sign up to get notified when there's something new on the Mylan Insulin Glargine Safety Clinical Trial page.

Latest updates to the Mylan Insulin Glargine Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added. The previous revision (v3.4.1) with funding and operating-status notices was removed.SummaryDifference0.3%

- Check21 days agoChange DetectedA government funding notice was added and the revision version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated footer metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page footer now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section and included state listings (California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, Texas); removed the individual California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, and Texas Location subsections. The page revision was updated to v3.3.3 (replacing v3.3.2) and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.8%

- Check85 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2. No substantive changes to the study details or page content are visible.SummaryDifference0.0%

Stay in the know with updates to Mylan Insulin Glargine Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mylan Insulin Glargine Safety Clinical Trial page.